Skip to main content

Open Ledger

Novo Nordisk financials in Beancount

Sector: Healthcare

Novo Nordisk keeps 6 recorded periods through FY2026Q3 as a balanced Beancount ledger — inspect the figures below, then open the live books.

Updated

View the live ledger

Latest figures

Revenue
DKK 79.2B (79,195 MDKK)
Net income
DKK 16.7B (16,740 MDKK)
Net margin
21.1%

Issuer filing (FY2026Q3)

Recorded history

Recorded revenue and net income in MDKK (Annual periods).
PeriodPeriod endRevenueNet income
FY2022December 31, 2022DKK 177B (176,954 MDKK)DKK 55.5B (55,525 MDKK)
FY2023December 31, 2023DKK 232.3B (232,261 MDKK)DKK 83.7B (83,683 MDKK)
FY2024December 31, 2024DKK 290.4B (290,403 MDKK)DKK 101B (100,988 MDKK)
FY2025December 31, 2025DKK 309.1B (309,064 MDKK)DKK 102.4B (102,434 MDKK)
Recorded revenue and net income in MDKK (Half-year periods).
Recorded revenue and net income in MDKK (Half-year periods).
PeriodPeriod endRevenueNet income
FY2026H1June 30, 2026DKK 175.3B (175,311 MDKK)DKK 69.5B (69,546 MDKK)
Recorded revenue and net income in MDKK (Quarter periods).
Recorded revenue and net income in MDKK (Quarter periods).
PeriodPeriod endRevenueNet income
FY2026Q3September 30, 2026DKK 79.2B (79,195 MDKK)DKK 16.7B (16,740 MDKK)

Coverage

Coverage6
  • FY2022
  • FY2023
  • FY2024
  • FY2025
  • FY2026H1
  • FY2026Q3

Earnings analyses

More companies in this sector